CenSyn

Curated by Signal

Provider of EEG for rapid screening of non-convulsive seizures in neuro-ICU patients

Overview

Provider of EEG for rapid screening of non-convulsive seizures in neuro-ICU patients. The company's proprietary product is CenSyn PenEEG which offers clinicians tools for immediate neurological assessments. The device can be used in the screening of Alzheimer's, traumatic brain injury, and epilepsy. The device is integrated with software and also uses AI-based technology for remote tele-neurology monitoring.

Key facts

Founded: 2019
Headquarters: Irvine, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

7 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

FOXO Technologies
Provider of epigenetic biomarkers discovery and development platform
Life Sciences TechnologyMinneapolis, United States
Denovicon Therapeutics
Provider of AI-based technology for drug discovery
Life Sciences TechnologySan Diego, United States
Moonwalk
Digital platform pioneering precision epigenetic medicines
Life Sciences TechnologySan Francisco, United States

About CenSyn

What does CenSyn do?

Provider of EEG for rapid screening of non-convulsive seizures in neuro-ICU patients.

Where is CenSyn headquartered?

CenSyn is headquartered in Irvine, United States.

When was CenSyn founded?

CenSyn was founded in 2019.

Which sector is CenSyn in?

CenSyn operates in Life Sciences Technology.

Who are CenSyn's competitors?

Companies similar to CenSyn include FOXO Technologies, Denovicon Therapeutics, and Moonwalk.